Sherriff, I believe the trial numbers may have been limited already by the amount of drug the company has left. I'm far from certain on this but recall hearing or reading a comment on this In the past. If this is the case, I suggest that an expanded trial would be unlikely.
INV103 - Results Due in July !, page-7
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 9849314 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6053724 | 25 |
View Market Depth
| Last trade - 16.12pm 11/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |
Day chart unavailable